{"entity":{"type":"insider","cik":"0001790029","url":"/insider/0001790029","json_url":"/insider/0001790029.json","name":"Bozic Carmen","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":22,"n_filings":22,"first":"2023-09-07","last":"2026-06-30","span_basis":"filed_date"},"name_variants":[{"name":"Bozic Carmen","source":"filing","n_filings":22,"first_seen":"2023-09-07","last_seen":"2026-06-30"}],"transactions":[{"id":5868414,"accession":"0000875320-26-000239","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000875320-26-000239","line_url":"/filing/0000875320-26-000239#line-1","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001790029","owner_name":"Bozic Carmen","owner_display_name":"Bozic Carmen","owner_url":"/insider/0001790029","role":"Officer (EVP and CMO)","role_mark":"O","role_mark_label":"Officer (EVP and CMO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":596.0,"shares_display":"596","price_per_share":482.5,"price_display":"482.50","price_state":"stated","total_value":287570.0,"total_display":"287,570.00","total_whole":"287,570","shares_owned_after":15337.0,"shares_owned_after_display":"15,337","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-26","filed_date":"2026-06-30","scope":"insider"},{"id":5926753,"accession":"0000875320-26-000237","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000875320-26-000237","line_url":"/filing/0000875320-26-000237#line-1","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001790029","owner_name":"Bozic Carmen","owner_display_name":"Bozic Carmen","owner_url":"/insider/0001790029","role":"Officer (EVP and CMO)","role_mark":"O","role_mark_label":"Officer (EVP and CMO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1020.0,"shares_display":"1,020","price_per_share":462.17,"price_display":"462.17","price_state":"stated","total_value":471413.4,"total_display":"471,413.40","total_whole":"471,413","shares_owned_after":15933.0,"shares_owned_after_display":"15,933","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-18","filed_date":"2026-06-23","scope":"insider"},{"id":5842722,"accession":"0000875320-26-000235","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000875320-26-000235","line_url":"/filing/0000875320-26-000235#line-1","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001790029","owner_name":"Bozic Carmen","owner_display_name":"Bozic Carmen","owner_url":"/insider/0001790029","role":"Officer (EVP and CMO)","role_mark":"O","role_mark_label":"Officer (EVP and CMO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4062.0,"shares_display":"4,062","price_per_share":450.0,"price_display":"450.00","price_state":"stated","total_value":1827900.0,"total_display":"1,827,900.00","total_whole":"1,827,900","shares_owned_after":16953.0,"shares_owned_after_display":"16,953","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-15","filed_date":"2026-06-17","scope":"insider"},{"id":6163793,"accession":"0000875320-26-000233","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000875320-26-000233","line_url":"/filing/0000875320-26-000233#line-1","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001790029","owner_name":"Bozic Carmen","owner_display_name":"Bozic Carmen","owner_url":"/insider/0001790029","role":"Officer (EVP and CMO)","role_mark":"O","role_mark_label":"Officer (EVP and CMO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1745.0,"shares_display":"1,745","price_per_share":450.0,"price_display":"450.00","price_state":"stated","total_value":785250.0,"total_display":"785,250.00","total_whole":"785,250","shares_owned_after":21015.0,"shares_owned_after_display":"21,015","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-05","filed_date":"2026-06-09","scope":"insider"},{"id":5914594,"accession":"0000875320-26-000228","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000875320-26-000228","line_url":"/filing/0000875320-26-000228#line-1","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001790029","owner_name":"Bozic Carmen","owner_display_name":"Bozic Carmen","owner_url":"/insider/0001790029","role":"Officer (EVP and CMO)","role_mark":"O","role_mark_label":"Officer (EVP and CMO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1974.0,"shares_display":"1,974","price_per_share":450.0,"price_display":"450.00","price_state":"stated","total_value":888300.0,"total_display":"888,300.00","total_whole":"888,300","shares_owned_after":22760.0,"shares_owned_after_display":"22,760","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-29","filed_date":"2026-06-02","scope":"insider"},{"id":5768105,"accession":"0000875320-26-000225","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000875320-26-000225","line_url":"/filing/0000875320-26-000225#line-1","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001790029","owner_name":"Bozic Carmen","owner_display_name":"Bozic Carmen","owner_url":"/insider/0001790029","role":"Officer (EVP and CMO)","role_mark":"O","role_mark_label":"Officer (EVP and CMO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1354.0,"shares_display":"1,354","price_per_share":453.45,"price_display":"453.45","price_state":"stated","total_value":613971.3,"total_display":"613,971.30","total_whole":"613,971","shares_owned_after":24734.0,"shares_owned_after_display":"24,734","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-15","filed_date":"2026-05-19","scope":"insider"},{"id":6145552,"accession":"0000875320-26-000222","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000875320-26-000222","line_url":"/filing/0000875320-26-000222#line-1","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001790029","owner_name":"Bozic Carmen","owner_display_name":"Bozic Carmen","owner_url":"/insider/0001790029","role":"Officer (EVP and CMO)","role_mark":"O","role_mark_label":"Officer (EVP and CMO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6988.0,"shares_display":"6,988","price_per_share":450.0,"price_display":"450.00","price_state":"stated","total_value":3144600.0,"total_display":"3,144,600.00","total_whole":"3,144,600","shares_owned_after":26088.0,"shares_owned_after_display":"26,088","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-12","filed_date":"2026-05-14","scope":"insider"},{"id":5914592,"accession":"0000875320-26-000149","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000875320-26-000149","line_url":"/filing/0000875320-26-000149#line-1","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001790029","owner_name":"Bozic Carmen","owner_display_name":"Bozic Carmen","owner_url":"/insider/0001790029","role":"Officer (EVP and CMO)","role_mark":"O","role_mark_label":"Officer (EVP and CMO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2329.0,"shares_display":"2,329","price_per_share":450.95,"price_display":"450.95","price_state":"stated","total_value":1050262.55,"total_display":"1,050,262.55","total_whole":"1,050,263","shares_owned_after":33076.0,"shares_owned_after_display":"33,076","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-27","filed_date":"2026-03-31","scope":"insider"},{"id":6103997,"accession":"0000875320-26-000140","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000875320-26-000140","line_url":"/filing/0000875320-26-000140#line-1","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001790029","owner_name":"Bozic Carmen","owner_display_name":"Bozic Carmen","owner_url":"/insider/0001790029","role":"Officer (EVP and CMO)","role_mark":"O","role_mark_label":"Officer (EVP and CMO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2329.0,"shares_display":"2,329","price_per_share":481.79,"price_display":"481.79","price_state":"stated","total_value":1122088.91,"total_display":"1,122,088.91","total_whole":"1,122,089","shares_owned_after":35405.0,"shares_owned_after_display":"35,405","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-13","filed_date":"2026-03-17","scope":"insider"},{"id":6069356,"accession":"0000875320-26-000127","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000875320-26-000127","line_url":"/filing/0000875320-26-000127#line-1","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001790029","owner_name":"Bozic Carmen","owner_display_name":"Bozic Carmen","owner_url":"/insider/0001790029","role":"Officer (EVP and CMO)","role_mark":"O","role_mark_label":"Officer (EVP and CMO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2329.0,"shares_display":"2,329","price_per_share":480.31,"price_display":"480.31","price_state":"stated","total_value":1118641.99,"total_display":"1,118,641.99","total_whole":"1,118,642","shares_owned_after":37734.0,"shares_owned_after_display":"37,734","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-27","filed_date":"2026-03-03","scope":"insider"},{"id":3105723,"accession":"0000875320-24-000202","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000875320-24-000202","line_url":"/filing/0000875320-24-000202#line-1","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001790029","owner_name":"Bozic Carmen","owner_display_name":"Bozic Carmen","owner_url":"/insider/0001790029","role":"Officer (EVP and CMO)","role_mark":"O","role_mark_label":"Officer (EVP and CMO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2280.0,"shares_display":"2,280","price_per_share":476.75,"price_display":"476.75","price_state":"stated","total_value":1086990.0,"total_display":"1,086,990.00","total_whole":"1,086,990","shares_owned_after":23259.0,"shares_owned_after_display":"23,259","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-07","filed_date":"2024-08-08","scope":"insider"},{"id":2411981,"accession":"0000875320-24-000189","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000875320-24-000189","line_url":"/filing/0000875320-24-000189#line-1","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001790029","owner_name":"Bozic Carmen","owner_display_name":"Bozic Carmen","owner_url":"/insider/0001790029","role":"Officer (EVP and CMO)","role_mark":"O","role_mark_label":"Officer (EVP and CMO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2280.0,"shares_display":"2,280","price_per_share":488.46,"price_display":"488.46","price_state":"stated","total_value":1113688.8,"total_display":"1,113,688.80","total_whole":"1,113,689","shares_owned_after":25539.0,"shares_owned_after_display":"25,539","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-07-24","filed_date":"2024-07-25","scope":"insider"},{"id":2137786,"accession":"0000875320-24-000183","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000875320-24-000183","line_url":"/filing/0000875320-24-000183#line-1","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001790029","owner_name":"Bozic Carmen","owner_display_name":"Bozic Carmen","owner_url":"/insider/0001790029","role":"Officer (EVP and CMO)","role_mark":"O","role_mark_label":"Officer (EVP and CMO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2280.0,"shares_display":"2,280","price_per_share":487.34,"price_display":"487.34","price_state":"stated","total_value":1111135.2,"total_display":"1,111,135.20","total_whole":"1,111,135","shares_owned_after":27819.0,"shares_owned_after_display":"27,819","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-07-10","filed_date":"2024-07-12","scope":"insider"},{"id":3012499,"accession":"0000875320-24-000181","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000875320-24-000181","line_url":"/filing/0000875320-24-000181#line-1","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001790029","owner_name":"Bozic Carmen","owner_display_name":"Bozic Carmen","owner_url":"/insider/0001790029","role":"Officer (EVP and CMO)","role_mark":"O","role_mark_label":"Officer (EVP and CMO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2280.0,"shares_display":"2,280","price_per_share":471.72,"price_display":"471.72","price_state":"stated","total_value":1075521.6,"total_display":"1,075,521.60","total_whole":"1,075,522","shares_owned_after":30099.0,"shares_owned_after_display":"30,099","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-26","filed_date":"2024-06-28","scope":"insider"},{"id":2299422,"accession":"0000875320-24-000176","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000875320-24-000176","line_url":"/filing/0000875320-24-000176#line-1","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001790029","owner_name":"Bozic Carmen","owner_display_name":"Bozic Carmen","owner_url":"/insider/0001790029","role":"Officer (EVP and CMO)","role_mark":"O","role_mark_label":"Officer (EVP and CMO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2280.0,"shares_display":"2,280","price_per_share":478.0,"price_display":"478.00","price_state":"stated","total_value":1089840.0,"total_display":"1,089,840.00","total_whole":"1,089,840","shares_owned_after":32379.0,"shares_owned_after_display":"32,379","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-12","filed_date":"2024-06-13","scope":"insider"},{"id":2620787,"accession":"0000875320-24-000164","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000875320-24-000164","line_url":"/filing/0000875320-24-000164#line-1","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001790029","owner_name":"Bozic Carmen","owner_display_name":"Bozic Carmen","owner_url":"/insider/0001790029","role":"Officer (EVP and CMO)","role_mark":"O","role_mark_label":"Officer (EVP and CMO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2280.0,"shares_display":"2,280","price_per_share":445.56,"price_display":"445.56","price_state":"stated","total_value":1015876.8,"total_display":"1,015,876.80","total_whole":"1,015,877","shares_owned_after":34659.0,"shares_owned_after_display":"34,659","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-29","filed_date":"2024-05-31","scope":"insider"},{"id":8643798,"accession":"0000875320-23-000037","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000875320-23-000037","line_url":"/filing/0000875320-23-000037#line-1","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001790029","owner_name":"Bozic Carmen","owner_display_name":"Bozic Carmen","owner_url":"/insider/0001790029","role":"Officer (EVP and CMO)","role_mark":"O","role_mark_label":"Officer (EVP and CMO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5650.0,"shares_display":"5,650","price_per_share":380.82,"price_display":"380.82","price_state":"stated","total_value":2151633.0,"total_display":"2,151,633.00","total_whole":"2,151,633","shares_owned_after":29302.0,"shares_owned_after_display":"29,302","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-14","filed_date":"2023-11-16","scope":"insider"},{"id":8032016,"accession":"0000875320-23-000025","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000875320-23-000025","line_url":"/filing/0000875320-23-000025#line-1","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001790029","owner_name":"Bozic Carmen","owner_display_name":"Bozic Carmen","owner_url":"/insider/0001790029","role":"Officer (EVP and CMO)","role_mark":"O","role_mark_label":"Officer (EVP and CMO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5651.0,"shares_display":"5,651","price_per_share":355.92,"price_display":"355.92","price_state":"stated","total_value":2011303.92,"total_display":"2,011,303.92","total_whole":"2,011,304","shares_owned_after":34952.0,"shares_owned_after_display":"34,952","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-10-31","filed_date":"2023-11-02","scope":"insider"},{"id":7871930,"accession":"0001209191-23-053178","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-053178","line_url":"/filing/0001209191-23-053178#line-1","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001790029","owner_name":"Bozic Carmen","owner_display_name":"Bozic Carmen","owner_url":"/insider/0001790029","role":"Officer (EVP and CMO)","role_mark":"O","role_mark_label":"Officer (EVP and CMO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5651.0,"shares_display":"5,651","price_per_share":373.25,"price_display":"373.25","price_state":"stated","total_value":2109235.75,"total_display":"2,109,235.75","total_whole":"2,109,236","shares_owned_after":40603.0,"shares_owned_after_display":"40,603","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-10-17","filed_date":"2023-10-19","scope":"insider"},{"id":8079095,"accession":"0001209191-23-052202","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-052202","line_url":"/filing/0001209191-23-052202#line-1","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001790029","owner_name":"Bozic Carmen","owner_display_name":"Bozic Carmen","owner_url":"/insider/0001790029","role":"Officer (EVP and CMO)","role_mark":"O","role_mark_label":"Officer (EVP and CMO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5651.0,"shares_display":"5,651","price_per_share":345.28,"price_display":"345.28","price_state":"stated","total_value":1951177.28,"total_display":"1,951,177.28","total_whole":"1,951,177","shares_owned_after":46254.0,"shares_owned_after_display":"46,254","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-10-03","filed_date":"2023-10-05","scope":"insider"},{"id":8609104,"accession":"0001209191-23-050259","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-050259","line_url":"/filing/0001209191-23-050259#line-1","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001790029","owner_name":"Bozic Carmen","owner_display_name":"Bozic Carmen","owner_url":"/insider/0001790029","role":"Officer (EVP and CMO)","role_mark":"O","role_mark_label":"Officer (EVP and CMO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5651.0,"shares_display":"5,651","price_per_share":351.0,"price_display":"351.00","price_state":"stated","total_value":1983501.0,"total_display":"1,983,501.00","total_whole":"1,983,501","shares_owned_after":51905.0,"shares_owned_after_display":"51,905","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-19","filed_date":"2023-09-21","scope":"insider"},{"id":8189717,"accession":"0001209191-23-048624","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-048624","line_url":"/filing/0001209191-23-048624#line-1","is_derivative":false,"issuer_cik":"0000875320","issuer_name":"VERTEX PHARMACEUTICALS INC / MA","issuer_ticker":"VRTX","issuer_name_source":null,"issuer_url":"/issuer/0000875320","owner_cik":"0001790029","owner_name":"Bozic Carmen","owner_display_name":"Bozic Carmen","owner_url":"/insider/0001790029","role":"Officer (EVP and CMO)","role_mark":"O","role_mark_label":"Officer (EVP and CMO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP and CMO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5651.0,"shares_display":"5,651","price_per_share":352.66,"price_display":"352.66","price_state":"stated","total_value":1992881.66,"total_display":"1,992,881.66","total_whole":"1,992,882","shares_owned_after":57556.0,"shares_owned_after_display":"57,556","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-05","filed_date":"2023-09-07","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":22,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":22,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":22},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000875320","name":"VERTEX PHARMACEUTICALS INC / MA","url":"/issuer/0000875320","role":"Officer (EVP and CMO)","n_filings":22,"first_seen":"2023-09-07","last_seen":"2026-06-30"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001790029","retrieved_at":"2026-08-26T14:29:45+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}